{"title":"Alaris® GP, GP Guardrails®, GP Plus and GP Plus Guardrails - risk of interruption to therapy","public_updated_at":"2014-12-17T15:01:44Z","details":{"metadata":{"alert_type":"devices","issued_date":"2013-08-08","medical_specialism":["anaesthetics","critical-care","haematology-oncology","paediatrics","renal-medicine","theatre-practitioners"],"bulk_published":true,"document_type":"medical_safety_alert"},"change_history":[{"id":66773,"note":"First published.","public_timestamp":"2014-12-17T15:01:44Z","edition_id":999311,"created_at":"2017-05-12T10:03:03Z","updated_at":"2017-05-12T10:03:03Z","content_id":"d3957d15-a2f1-4a12-b9d8-7fa103b23983"}],"body":[{"content_type":"text/html","content":"<h2 id=\"cas-deadlines\">CAS deadlines</h2>\n<p>Action underway: 22 August 2013, action complete: 06 September 2013  </p>\n\n<p>Note: These deadlines are for systems to be in place to identify pumps and to arrange for motor replacements.</p>\n\n<h2 id=\"device\">Device</h2>\n\n<p>Infusion pumps: Alaris® GP, GP Guardrails®, GP Plus and GP Plus Guardrails</p>\n\n<p>Manufactured by CareFusion.</p>\n\n<p>Specific serial numbers are affected.</p>\n\n<p>General purpose volumetric infusion pumps intended for acute and sub-acute applications.</p>\n\n<p>Product codes: 80263UN01, 80263UN01-G, 9002MED01, 9002MED01-G.</p>\n\n<p>The serial numbers of affected pumps are specific to each customer. <br />\nContact your local biomedical engineering department to obtain this list or contact CareFusion directly to determine which pumps are affected. <br />\nThe serial number is printed on the back of each pump. </p>\n\n<p>The MHRA does not possess a list of affected serial numbers.</p>\n\n<p><img src=\"https://assets.digital.cabinet-office.gov.uk/media/5485ab5de5274a429000023d/con300414.jpg\" alt=\"Infusion pumps\" /></p>\n\n<h2 id=\"problem\">Problem</h2>\n\n<p>Risk of interruption to therapy.</p>\n\n<p>A fault with the front and rear bearings of the pump’s stepper motor may cause the pump to stall during an infusion. The pump stops, alarms and displays a ‘DRV1’ or ‘DRV2’ error on the screen.</p>\n\n<p>Replacement of the motors will begin in September 2013.</p>\n\n<p>CareFusion issued a <a rel=\"external\" href=\"https://assets.digital.cabinet-office.gov.uk/media/5485ab5ced915d4c1000020d/con286888.pdf\">Field Safety Notice</a> (245Kb) (FSN) in May 2013.</p>\n\n<p>The motor stall condition may occur during start-up (immediately after the start key is pressed) or during an infusion, which may result in the early termination of an infusion. Early termination of an infusion could require intervention especially if critical drugs are being administered.</p>\n\n<h2 id=\"action\">Action</h2>\n\n<ul>\n  <li>Identify affected pumps.  </li>\n  <li>Consider using an alternative pump, particularly if an interruption to an infusion could compromise patient safety.  </li>\n  <li>If an alternative pump is not available, follow the advice in the manufacturer’s instructions for use. In particular if a ‘DRV1 or DRV2’ error is displayed, immediately remove the pump from use and contact CareFusion.  </li>\n  <li>Return completed verification form in the FSN to CareFusion.  </li>\n  <li>When available, ensure the stepper motors are replaced.  </li>\n</ul>\n\n<h3 id=\"action-by\">Action by</h3>\n\n<p>Risk managers, clinical and biomedical personnel who use, maintain, and are responsible for these pumps.</p>\n\n<h2 id=\"distribution\">Distribution</h2>\n\n<p>This MDA has been sent to:  </p>\n\n<ul>\n  <li>Care Quality Commission (CQC) (headquarters) for information  </li>\n  <li>Clinical commissioning groups (CCGs)  </li>\n  <li>HSC trusts in Northern Ireland (chief executives)  </li>\n  <li>Local authorities in Scotland (equipment coordinators)  </li>\n  <li>NHS boards and trusts in Wales (chief executives)  </li>\n  <li>NHS boards in Scotland (equipment coordinators)  </li>\n  <li>NHS England area teams (for information)  </li>\n  <li>NHS trusts in England (chief executives)  </li>\n</ul>\n\n<h3 id=\"onward-distribution\">Onward distribution</h3>\n\n<p>Please bring this notice to the attention of relevant employees in your establishment. <br />\nBelow is a suggested list of recipients.</p>\n\n<p>Trusts<br />\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  </p>\n\n<ul>\n  <li>A&amp;E departments  </li>\n  <li>Adult intensive care units  </li>\n  <li>All wards  </li>\n  <li>All clinical areas  </li>\n  <li>Anaesthesia, directors of  </li>\n  <li>Biomedical engineering staff  </li>\n  <li>Clinical governance leads  </li>\n  <li>Community hospitals  </li>\n  <li>EBME departments  </li>\n  <li>Equipment libraries  </li>\n  <li>Health and safety managers  </li>\n  <li>In-house maintenance staff  </li>\n  <li>IV nurse specialists  </li>\n  <li>Medical directors  </li>\n  <li>Nursing executive directors  </li>\n  <li>Outpatient departments  </li>\n  <li>Paediatric intensive care units  </li>\n  <li>Risk managers  </li>\n  <li>Special care baby units  </li>\n  <li>Supplies managers  </li>\n  <li>Theatres  </li>\n</ul>\n\n<h3 id=\"independent-distribution\">Independent distribution</h3>\n\n<p>Establishments registered with the Care Quality Commission (CQC) (England only)<br />\nThis alert should be read by:  </p>\n\n<ul>\n  <li>Care homes providing nursing care (adults)  </li>\n  <li>Clinics  </li>\n  <li>Hospitals in the independent sector  </li>\n  <li>Independent treatment centres  </li>\n  <li>Nursing agencies  </li>\n  <li>Private medical practitioners  </li>\n</ul>\n\n<p>Please note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health’s Central Alerting System (CAS) by sending an email to: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#115;&#097;&#102;&#101;&#116;&#121;&#097;&#108;&#101;&#114;&#116;&#115;&#064;&#100;&#104;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#115;&#097;&#102;&#101;&#116;&#121;&#097;&#108;&#101;&#114;&#116;&#115;&#064;&#100;&#104;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a> and requesting this facility.</p>\n\n<h2 id=\"manufacturer-contact\">Manufacturer contact</h2>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nSue Briggs  \n<br />Customer Care  \n<br />CareFusion UK Ltd  \n<br />Basingstoke  \n<br />RG22 4BS  \n<br />Tel: 0800 917 8776   \n<br />\n</p></div></div>\n\n<p>Email:    <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#071;&#045;&#066;&#097;&#115;&#045;&#067;&#117;&#115;&#116;&#111;&#109;&#101;&#114;&#045;&#083;&#101;&#114;&#118;&#105;&#099;&#101;&#064;&#099;&#097;&#114;&#101;&#102;&#117;&#115;&#105;&#111;&#110;&#046;&#099;&#111;&#109;\">&#071;&#045;&#066;&#097;&#115;&#045;&#067;&#117;&#115;&#116;&#111;&#109;&#101;&#114;&#045;&#083;&#101;&#114;&#118;&#105;&#099;&#101;&#064;&#099;&#097;&#114;&#101;&#102;&#117;&#115;&#105;&#111;&#110;&#046;&#099;&#111;&#109;</a></p>\n\n<h2 id=\"feedback\">Feedback</h2>\n\n<p>If you have any comments or feedback on this Medical Device Alert please email us at: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#100;&#116;&#115;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#100;&#116;&#115;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a>. </p>\n\n<h2 id=\"england\">England</h2>\n\n<p>If you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2013/062 or 2013/006/007/291/002.</p>\n\n<h3 id=\"technical-aspects\">Technical aspects</h3>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nEnitan Taiwo and Roopa Prabhakar  \n<br />Medicines &amp; Healthcare Products Regulatory Agency  \n<br />Floor 4, 151 Buckingham Palace Road\n<br />London SW1W 9SZ  \n<br />\n<br />Tel:   020 3080 7122 / 7293    \n<br />Fax:   020 8754 3965  \n<br />\n</p></div></div>\n\n<p>Email:    <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#101;&#110;&#105;&#116;&#097;&#110;&#046;&#116;&#097;&#105;&#119;&#111;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#101;&#110;&#105;&#116;&#097;&#110;&#046;&#116;&#097;&#105;&#119;&#111;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a> or <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#114;&#111;&#111;&#112;&#097;&#046;&#112;&#114;&#097;&#098;&#104;&#097;&#107;&#097;&#114;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#114;&#111;&#111;&#112;&#097;&#046;&#112;&#114;&#097;&#098;&#104;&#097;&#107;&#097;&#114;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a></p>\n\n<h3 id=\"clinical-aspects\">Clinical aspects</h3>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nJonathan Plumb  \n<br />Medicines &amp; Healthcare Products Regulatory Agency  \n<br />Floor 4, 151 Buckingham Palace Road\n<br />London SW1W 9SZ  \n<br />\n<br />Tel:    020 3080 6648\n<br />Fax:     020 8754 3965  \n<br />\n</p></div></div>\n\n<p>Email:    <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#106;&#111;&#110;&#097;&#116;&#104;&#097;&#110;&#046;&#112;&#108;&#117;&#109;&#098;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#106;&#111;&#110;&#097;&#116;&#104;&#097;&#110;&#046;&#112;&#108;&#117;&#109;&#098;&#064;&#109;&#104;&#114;&#097;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a></p>\n\n<h3 id=\"how-to-report-adverse-incidents\">How to report adverse incidents</h3>\n\n<p>Please report via our website: <a rel=\"external\" href=\"http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm\">Reporting adverse incidents involving medical devices</a><br />\nFurther information about CAS can be found <a rel=\"external\" href=\"https://www.cas.dh.gov.uk/Home.aspx\">on the CAS website</a></p>\n\n<h2 id=\"northern-ireland\">Northern Ireland</h2>\n\n<p>Alerts in Northern Ireland will continue to be distributed via the NI SABS system.</p>\n\n<p>Enquiries and adverse incident reports in Northern Ireland should be addressed to:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nNorthern Ireland Adverse Incident Centre  \n<br />Health Estates Investment Group  \n<br />Room 17  \n<br />Annex 6  \n<br />Castle Buildings  \n<br />Stormont Estate  \n<br />Dundonald BT4 3SQ\n<br />\n<br />Tel: 02890 523 704  \n<br />Fax: 02890 523 900  \n<br />\n</p></div></div>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#078;&#073;&#065;&#073;&#067;&#064;&#100;&#104;&#115;&#115;&#112;&#115;&#110;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#078;&#073;&#065;&#073;&#067;&#064;&#100;&#104;&#115;&#115;&#112;&#115;&#110;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a></p>\n\n<h3 id=\"how-to-report-adverse-incidents-in-northern-ireland\">How to report adverse incidents in Northern Ireland</h3>\n\n<p>Please report directly to NIAIC, further information can be found on the <a rel=\"external\" href=\"http://www.dhsspsni.gov.uk/niaic\">NIAIC website</a> <br />\nFurther information about SABS can be found <a rel=\"external\" href=\"http://sabs.dhsspsni.gov.uk/\">on the SABS website</a></p>\n\n<h2 id=\"scotland\">Scotland</h2>\n\n<p>Enquiries and adverse incident reports in Scotland should be addressed to:</p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nIncident Reporting and Investigation Centre\n<br />Health Facilities Scotland  \n<br />NHS National Services Scotland  \n<br />Gyle Square  \n<br />1 South Gyle Crescent  \n<br />Edinburgh EH12 9EB\n<br />\n<br />Tel: 0131 275 7575  \n<br />Fax: 0131 314 0722\n<br />\n</p></div></div>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#110;&#115;&#115;&#046;&#105;&#114;&#105;&#099;&#064;&#110;&#104;&#115;&#046;&#110;&#101;&#116;\">&#110;&#115;&#115;&#046;&#105;&#114;&#105;&#099;&#064;&#110;&#104;&#115;&#046;&#110;&#101;&#116;</a></p>\n\n<h2 id=\"wales\">Wales</h2>\n\n<p>Enquiries in Wales should be addressed to:  </p>\n\n<div class=\"address\"><div class=\"adr org fn\"><p>\n\nImproving Patient Safety Team  \n<br />Medical Directorate  \n<br />Welsh Government  \n<br />Cathays Park  \n<br />Cardiff CF10 3NQ\n<br />\n<br />Tel: 029 2082 3922  \n<br />\n</p></div></div>\n\n<p>Email: <a href=\"&#109;&#097;&#105;&#108;&#116;&#111;:&#072;&#097;&#122;&#045;&#065;&#105;&#099;&#064;&#119;&#097;&#108;&#101;&#115;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;\">&#072;&#097;&#122;&#045;&#065;&#105;&#099;&#064;&#119;&#097;&#108;&#101;&#115;&#046;&#103;&#115;&#105;&#046;&#103;&#111;&#118;&#046;&#117;&#107;</a></p>\n\n<h3 id=\"download-documents\">Download documents</h3>\n\n<p><a rel=\"external\" href=\"https://assets.digital.cabinet-office.gov.uk/media/5485ab5d40f0b60244000227/con300415.pdf\"> Medical Device Alert: Infusion pumps: Alaris® GP, GP Guardrails®, GP Plus and GP Plus Guardrails manufactured by CareFusion (MDA/2013/062) (76Kb)</a></p>\n"},{"content_type":"text/govspeak","content":"##CAS deadlines  \r\nAction underway: 22 August 2013, action complete: 06 September 2013  \r\n  \r\nNote: These deadlines are for systems to be in place to identify pumps and to arrange for motor replacements.\r\n\r\n## Device\r\n\r\nInfusion pumps: Alaris® GP, GP Guardrails®, GP Plus and GP Plus Guardrails\r\n\r\nManufactured by CareFusion.\r\n\r\nSpecific serial numbers are affected.\r\n\r\nGeneral purpose volumetric infusion pumps intended for acute and sub-acute applications.\r\n\r\nProduct codes: 80263UN01, 80263UN01-G, 9002MED01, 9002MED01-G.\r\n\r\nThe serial numbers of affected pumps are specific to each customer.   \r\nContact your local biomedical engineering department to obtain this list or contact CareFusion directly to determine which pumps are affected.   \r\nThe serial number is printed on the back of each pump. \r\n\r\nThe MHRA does not possess a list of affected serial numbers.\r\n\r\n\r\n\r\n![InlineAttachment:con300414.jpg]\r\n\r\n\r\n\r\n## Problem\r\n\r\nRisk of interruption to therapy.\r\n\r\nA fault with the front and rear bearings of the pump’s stepper motor may cause the pump to stall during an infusion. The pump stops, alarms and displays a ‘DRV1’ or ‘DRV2’ error on the screen.\r\n\r\nReplacement of the motors will begin in September 2013.\r\n\r\nCareFusion issued a [InlineAttachment:con286888.pdf] (245Kb) (FSN) in May 2013.\r\n\r\nThe motor stall condition may occur during start-up (immediately after the start key is pressed) or during an infusion, which may result in the early termination of an infusion. Early termination of an infusion could require intervention especially if critical drugs are being administered.\r\n\r\n## Action  \r\n  \r\n  * Identify affected pumps.  \r\n  * Consider using an alternative pump, particularly if an interruption to an infusion could compromise patient safety.  \r\n  * If an alternative pump is not available, follow the advice in the manufacturer’s instructions for use. In particular if a ‘DRV1 or DRV2’ error is displayed, immediately remove the pump from use and contact CareFusion.  \r\n  * Return completed verification form in the FSN to CareFusion.  \r\n  * When available, ensure the stepper motors are replaced.  \r\n  \r\n### Action by\r\n\r\nRisk managers, clinical and biomedical personnel who use, maintain, and are responsible for these pumps.\r\n\r\n## Distribution\r\n\r\nThis MDA has been sent to:  \r\n  \r\n  * Care Quality Commission (CQC) (headquarters) for information  \r\n  * Clinical commissioning groups (CCGs)  \r\n  * HSC trusts in Northern Ireland (chief executives)  \r\n  * Local authorities in Scotland (equipment coordinators)  \r\n  * NHS boards and trusts in Wales (chief executives)  \r\n  * NHS boards in Scotland (equipment coordinators)  \r\n  * NHS England area teams (for information)  \r\n  * NHS trusts in England (chief executives)  \r\n  \r\n### Onward distribution\r\n\r\nPlease bring this notice to the attention of relevant employees in your establishment.   \r\nBelow is a suggested list of recipients.\r\n\r\nTrusts  \r\nCAS and SABS (NI) liaison officers for onward distribution to all relevant staff including:  \r\n  \r\n  * A&E departments  \r\n  * Adult intensive care units  \r\n  * All wards  \r\n  * All clinical areas  \r\n  * Anaesthesia, directors of  \r\n  * Biomedical engineering staff  \r\n  * Clinical governance leads  \r\n  * Community hospitals  \r\n  * EBME departments  \r\n  * Equipment libraries  \r\n  * Health and safety managers  \r\n  * In-house maintenance staff  \r\n  * IV nurse specialists  \r\n  * Medical directors  \r\n  * Nursing executive directors  \r\n  * Outpatient departments  \r\n  * Paediatric intensive care units  \r\n  * Risk managers  \r\n  * Special care baby units  \r\n  * Supplies managers  \r\n  * Theatres  \r\n  \r\n### Independent distribution\r\n\r\nEstablishments registered with the Care Quality Commission (CQC) (England only)  \r\nThis alert should be read by:  \r\n  \r\n  * Care homes providing nursing care (adults)  \r\n  * Clinics  \r\n  * Hospitals in the independent sector  \r\n  * Independent treatment centres  \r\n  * Nursing agencies  \r\n  * Private medical practitioners  \r\n  \r\nPlease note: CQC and OFSTED do not distribute these alerts. Independent healthcare providers and social care providers can sign up to receive MDAs directly from the Department of Health’s Central Alerting System (CAS) by sending an email to: [safetyalerts@dh.gsi.gov.uk](mailto:safetyalerts@dh.gsi.gov.uk) and requesting this facility.\r\n\r\n## Manufacturer contact\r\n\r\n\r\n$A\r\nSue Briggs  \r\nCustomer Care  \r\nCareFusion UK Ltd  \r\nBasingstoke  \r\nRG22 4BS  \r\nTel: 0800 917 8776   \r\n$A\r\n\r\nEmail:    [G-Bas-Customer-Service@carefusion.com](mailto:G-Bas-Customer-Service@carefusion.com)\r\n\r\n## Feedback\r\n\r\nIf you have any comments or feedback on this Medical Device Alert please email us at: [dts@mhra.gsi.gov.uk](mailto:dts@mhra.gsi.gov.uk). \r\n\r\n## England\r\n\r\nIf you are in England, please send enquiries about this notice to the MHRA, quoting reference number MDA/2013/062 or 2013/006/007/291/002.\r\n\r\n###Technical aspects  \r\n\r\n\r\n$A\r\nEnitan Taiwo and Roopa Prabhakar  \r\nMedicines & Healthcare Products Regulatory Agency  \r\nFloor 4, 151 Buckingham Palace Road\r\nLondon SW1W 9SZ  \r\n\r\nTel:   020 3080 7122 / 7293    \r\nFax:   020 8754 3965  \r\n$A\r\n\r\nEmail:    [enitan.taiwo@mhra.gsi.gov.uk](mailto:enitan.taiwo@mhra.gsi.gov.uk) or [roopa.prabhakar@mhra.gsi.gov.uk](mailto:roopa.prabhakar@mhra.gsi.gov.uk)\r\n\r\n###Clinical aspects  \r\n\r\n\r\n$A\r\nJonathan Plumb  \r\nMedicines & Healthcare Products Regulatory Agency  \r\nFloor 4, 151 Buckingham Palace Road\r\nLondon SW1W 9SZ  \r\n\r\nTel:    020 3080 6648\r\nFax:     020 8754 3965  \r\n$A\r\n\r\nEmail:    [jonathan.plumb@mhra.gsi.gov.uk](mailto:jonathan.plumb@mhra.gsi.gov.uk)\r\n\r\n### How to report adverse incidents\r\n\r\nPlease report via our website: [Reporting adverse incidents involving medical devices](http://www.mhra.gov.uk/Safetyinformation/Reportingsafetyproblems/Devices/index.htm)  \r\nFurther information about CAS can be found [on the CAS website](https://www.cas.dh.gov.uk/Home.aspx)\r\n\r\n\r\n## Northern Ireland\r\n\r\nAlerts in Northern Ireland will continue to be distributed via the NI SABS system.\r\n\r\nEnquiries and adverse incident reports in Northern Ireland should be addressed to:\r\n\r\n\r\n$A\r\nNorthern Ireland Adverse Incident Centre  \r\nHealth Estates Investment Group  \r\nRoom 17  \r\nAnnex 6  \r\nCastle Buildings  \r\nStormont Estate  \r\nDundonald BT4 3SQ\r\n\r\nTel: 02890 523 704  \r\nFax: 02890 523 900  \r\n$A\r\n\r\nEmail: [NIAIC@dhsspsni.gov.uk](mailto:NIAIC@dhsspsni.gov.uk)\r\n\r\n### How to report adverse incidents in Northern Ireland\r\n\r\nPlease report directly to NIAIC, further information can be found on the [NIAIC website](http://www.dhsspsni.gov.uk/niaic)   \r\nFurther information about SABS can be found [on the SABS website](http://sabs.dhsspsni.gov.uk/)\r\n\r\n## Scotland\r\n\r\nEnquiries and adverse incident reports in Scotland should be addressed to:\r\n\r\n\r\n$A\r\nIncident Reporting and Investigation Centre\r\nHealth Facilities Scotland  \r\nNHS National Services Scotland  \r\nGyle Square  \r\n1 South Gyle Crescent  \r\nEdinburgh EH12 9EB\r\n\r\nTel: 0131 275 7575  \r\nFax: 0131 314 0722\r\n$A\r\n\r\nEmail: [nss.iric@nhs.net](mailto:nss.iric@nhs.net)\r\n\r\n## Wales\r\n\r\nEnquiries in Wales should be addressed to:  \r\n\r\n\r\n$A\r\nImproving Patient Safety Team  \r\nMedical Directorate  \r\nWelsh Government  \r\nCathays Park  \r\nCardiff CF10 3NQ\r\n\r\nTel: 029 2082 3922  \r\n$A\r\n\r\nEmail: [Haz-Aic@wales.gsi.gov.uk](mailto:Haz-Aic@wales.gsi.gov.uk)\r\n\r\n### Download documents\r\n\r\n[InlineAttachment:con300415.pdf]"}],"max_cache_time":10,"temporary_update_type":false,"attachments":[{"content_id":"ec72511b-5257-4f16-bf11-aab6f830e36d","title":"Field Safety Notice","url":"https://assets.digital.cabinet-office.gov.uk/media/5485ab5ced915d4c1000020d/con286888.pdf","updated_at":"2014-12-08T13:45:00Z","created_at":"2014-12-08T13:45:01Z","content_type":"application/pdf"},{"content_id":"961065e2-2762-4f9a-acc9-430347f1662b","title":" Medical Device Alert: Infusion pumps: Alaris® GP, GP Guardrails®, GP Plus and GP Plus Guardrails manufactured by CareFusion (MDA/2013/062) (76Kb)","url":"https://assets.digital.cabinet-office.gov.uk/media/5485ab5d40f0b60244000227/con300415.pdf","updated_at":"2014-12-08T13:45:00Z","created_at":"2014-12-08T13:45:01Z","content_type":"application/pdf"},{"content_id":"637032e9-be33-45a0-a48f-df5dcb7dcac9","title":"Infusion pumps","url":"https://assets.digital.cabinet-office.gov.uk/media/5485ab5de5274a429000023d/con300414.jpg","updated_at":"2014-12-08T13:45:01Z","created_at":"2014-12-08T13:45:01Z","content_type":"application/jpg"}],"headers":[{"text":"CAS deadlines","level":2,"id":"cas-deadlines"},{"text":"Device","level":2,"id":"device"},{"text":"Problem","level":2,"id":"problem"},{"text":"Action","level":2,"id":"action","headers":[{"text":"Action by","level":3,"id":"action-by"}]},{"text":"Distribution","level":2,"id":"distribution","headers":[{"text":"Onward distribution","level":3,"id":"onward-distribution"},{"text":"Independent distribution","level":3,"id":"independent-distribution"}]},{"text":"Manufacturer contact","level":2,"id":"manufacturer-contact"},{"text":"Feedback","level":2,"id":"feedback"},{"text":"England","level":2,"id":"england","headers":[{"text":"Technical aspects","level":3,"id":"technical-aspects"},{"text":"Clinical aspects","level":3,"id":"clinical-aspects"},{"text":"How to report adverse incidents","level":3,"id":"how-to-report-adverse-incidents"}]},{"text":"Northern Ireland","level":2,"id":"northern-ireland","headers":[{"text":"How to report adverse incidents in Northern Ireland","level":3,"id":"how-to-report-adverse-incidents-in-northern-ireland"}]},{"text":"Scotland","level":2,"id":"scotland"},{"text":"Wales","level":2,"id":"wales","headers":[{"text":"Download documents","level":3,"id":"download-documents"}]}]},"routes":[{"path":"/drug-device-alerts/medical-device-alert-alaris-gp-gp-guardrails-gp-plus-and-gp-plus-guardrails-risk-of-interruption-to-therapy","type":"exact"}],"redirects":[],"publishing_app":"specialist-publisher","rendering_app":"government-frontend","need_ids":[],"phase":"live","analytics_identifier":null,"document_type":"medical_safety_alert","schema_name":"specialist_document","first_published_at":null,"base_path":"/drug-device-alerts/medical-device-alert-alaris-gp-gp-guardrails-gp-plus-and-gp-plus-guardrails-risk-of-interruption-to-therapy","description":"(CareFusion) Pump may stop, alarm and display a ‘DRV1’ or ‘DRV2’ error on the screen. (MDA/2013/062)","content_id":"d3957d15-a2f1-4a12-b9d8-7fa103b23983","locale":"en","expanded_links":{"organisations":[{"analytics_identifier":"EA63","api_path":"/api/content/government/organisations/medicines-and-healthcare-products-regulatory-agency","base_path":"/government/organisations/medicines-and-healthcare-products-regulatory-agency","content_id":"240f72bd-9a4d-4f39-94d9-77235cadde8e","description":null,"document_type":"organisation","locale":"en","public_updated_at":"2015-06-29T14:33:29Z","schema_name":"placeholder","title":"Medicines and Healthcare products Regulatory Agency","withdrawn":false,"details":{"brand":"department-of-health","logo":{"formatted_title":"Medicines &amp; Healthcare products<br/>Regulatory Agency","crest":"single-identity"}},"links":{}}],"finder":[{"analytics_identifier":null,"api_path":"/api/content/drug-device-alerts","base_path":"/drug-device-alerts","content_id":"1e9c0ada-5f7e-43cc-a55f-cc32757edaa3","description":"Find alerts and recalls issued by MHRA","document_type":"finder","locale":"en","public_updated_at":"2017-03-30T10:34:00Z","schema_name":"finder","title":"Alerts and recalls for drugs and medical devices","withdrawn":false,"details":{"document_noun":"alert","filter":{"document_type":"medical_safety_alert"},"format_name":"Medical safety alert","show_summaries":true,"facets":[{"key":"alert_type","name":"Alert type","type":"text","preposition":"for","display_as_result_metadata":true,"filterable":true,"allowed_values":[{"label":"Drug alert","value":"drugs"},{"label":"Medical device alert","value":"devices"},{"label":"Field safety notice","value":"field-safety-notices"},{"label":"Drug alert: company-led","value":"company-led-drugs"}]},{"key":"medical_specialism","name":"Medical specialism","type":"text","preposition":"about","display_as_result_metadata":true,"filterable":true,"allowed_values":[{"label":"Anaesthetics","value":"anaesthetics"},{"label":"Cardiology","value":"cardiology"},{"label":"Care home staff","value":"care-home-staff"},{"label":"Cosmetic surgery","value":"cosmetic-surgery"},{"label":"Critical care","value":"critical-care"},{"label":"Dentistry","value":"dentistry"},{"label":"General practice","value":"general-practice"},{"label":"General surgery","value":"general-surgery"},{"label":"Haematology and oncology","value":"haematology-oncology"},{"label":"Infection prevention","value":"infection-prevention"},{"label":"Obstetrics and gynaecology","value":"obstetrics-gynaecology"},{"label":"Ophthalmology","value":"ophthalmology"},{"label":"Orthopaedics","value":"orthopaedics"},{"label":"Paediatrics","value":"paediatrics"},{"label":"Pathology","value":"pathology"},{"label":"Pharmacy","value":"pharmacy"},{"label":"Physiotherapy and occupational therapy","value":"physiotherapy-occupational-therapy"},{"label":"Radiology","value":"radiology"},{"label":"Renal medicine","value":"renal-medicine"},{"label":"Theatre practitioners","value":"theatre-practitioners"},{"label":"Urology","value":"urology"},{"label":"Vascular and cardiac surgery","value":"vascular-cardiac-surgery"}]},{"key":"issued_date","name":"Issued","short_name":"Issued","type":"date","preposition":"issued","display_as_result_metadata":true,"filterable":true}],"default_documents_per_page":50},"links":{}}]},"format":"specialist_document","navigation_document_supertype":"other","user_journey_document_supertype":"thing","email_document_supertype":"other","government_document_supertype":"other","payload_version":0}